BioWorld - Saturday, March 14, 2026

BioWorld Science

April 14, 2011

View Archived Issues

Abbott presents new ROCK-2 inhibitor with high specificity and selectivity

Read More

First-in-human data reported on GDC-0973 alone and in combination with GDC-0941

Read More

Pfizer's new HSP 90 inhibitor PF-4942847 shows promise in triple-negative breast cancer in vivo

Read More

Levels of pentraxin-related protein PTX3 may predict unresponsiveness to IVIG in Kawasaki's disease

Read More

Vanderbilt University patents new modulators of metabotropic glutamate mGlu5 receptor

Read More

Israeli scientists present new DJ-1-related peptides for neurodegenerative diseases

Read More

Suven patents novel serotonin 5-HT4 receptor modulators

Read More

Recordati discloses novel metabotropic glutamate mGlu5 receptor antagonists

Read More

New 17-beta-HSD 3 inhibitors prepared by Sumitomo

Read More

Vernalis regains rights to adenosine A2A receptor antagonists from Biogen Idec

Read More

APEPTICO begins phase I AP-301 trial in pulmonary edema

Read More

FDA sets PDUFA date for Teva Pharma's Bio-T-Gel NDA

Read More

PharmAthene completes dosing in phase I Valortim trial for inhalational anthrax

Read More

Intellect Neurosciences files FDA orphan drug application for OX-1 in Friedreich's ataxia

Read More

Cellmid and Antitope to collaborate on humanization of midkine-directed antibodies

Read More

Myriad Genetics to conduct mutation testing for BioMarin's phase I/II BMN-673 trial

Read More

4SC grants Yakult Honsha license to resminostat in Japan

Read More